We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Accessing Pharma Markets in Eastern Europe
News

Accessing Pharma Markets in Eastern Europe

Accessing Pharma Markets in Eastern Europe
News

Accessing Pharma Markets in Eastern Europe

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Accessing Pharma Markets in Eastern Europe"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

In this new market reality, pharma companies still need to find a way to capture maximum business potential in these key regions.

In order to discuss major concerns and overcome challenges resulting from these tendencies throughout the region, Fleming Europe is organizing a brand new conference – Pharma Excellence in the CEE, CIS, SEE and Turkey. A number of top-level pharmaceutical experts have accepted the invitation to present their strategies to accelerate market access and to ensure maximum return on investment, in the beautiful city of Budapest, on 14 – 15 June 2012.

“Fleming Europe has decided to create a platform where leading Pharma specialists from Turkey and countries of the CEE, CIS and SEE would gather to discuss and to resolve the most pressing issues dominating the region,” Jana Chocholova, conference producer explained.

This 2-day conference will be structured into presentations and interactive panel discussions focused on topics such as – opportunities and challenges within diversified market environments, the importance of clinical and economic value in market access, major regulatory concerns, payers' roles in the entire product life-cycle, critical insight into the HTA processes in the region, successful pathways for product launch, closed loop marketing, strategies to increase SFE and many more.

Regional pharmaceutical experts from Eli Lilly, Novartis, Teva, Zentiva, Mylan, Pfizer, Sanofi, Merck, Roche, GSK, AstraZeneca, Abbott, etc. will participate in this unique conference to share their knowledge and experience with you.
Advertisement